Engineering Bacteria for Drug Delivery

Biologists have engineered bacteria to continuously deliver drugs into the intestine, providing a novel approach for treating chronic inflammation and obesity. This innovation involves modifying gut bacteria to produce protein-based drugs, allowing for a steady release of medication over time. The effectiveness of this method was demonstrated in mice, highlighting the potential for future applications in humans. By utilizing the natural microbiome, this technique could transform how certain diseases are managed, minimizing the need for injections and enhancing patient compliance.